LogicBio Therapeutics Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$129.5M
Industry:Biotech
Founded:N/A
Lead Investor(s):N/A
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • LogicBio Therapeutics's estimated annual revenue is currently $4M per year.
  • LogicBio Therapeutics received $50.0M in venture funding in June 2017.
  • LogicBio Therapeutics's estimated revenue per employee is $89,556
  • LogicBio Therapeutics's total funding is $129.5M.

Employee Data

  • LogicBio Therapeutics has 45 Employees.
  • LogicBio Therapeutics grew their employee count by 15% last year.
  • LogicBio Therapeutics currently has 3 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$7.1M4659%N/A
Tango Therapeut...
$9M5841%N/A
Compass Therape...
$15.8M10215%N/A
Cell Signaling ...
$75.6M488N/AN/A
Momenta Pharmac...
N/A212N/AN/A
Emulate
$14.7M95-17%N/A
ArQule
N/A90N/AN/A
Hamilton Storag...
$14.6M949%N/A
Alnylam Pharmac...
$74.9M122831%N/A
Transgenomic
N/A45N/AN/A
Missing a competitor? Contribute!?
Submit

We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases. GeneRide is a promoterless and nuclease-free approach to gene insertion which may improve the safety profile of AAV based gene therapies With GeneRide, the therapeutic gene is site-specifically integrated into the genome allowing durable gene expression in dividing cells and mature tissues. Furthermore, therapeutic gene expression is regulated by the targeted locus so production can be limited to specific cell types.

keywords:N/A

45

Number of Employees

$4M

Revenue (est)

3

Current Jobs

15%

Employee Growth %

$129.5M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Susana GordoDirector
Sven LoebrichDirector Process Development
Marcia FarrowAssociate Director Clinical Trial Operations
Kyle ChiangVP Product StrategyEmail Available
Jessie HaighExecutive Assistant to the CEO and Office ManagerEmail Available
Chris CummingsPrincipal Research Associate
Jing LiaoAssociate Director
Nelson ChauVP, Discovery Biology and Translational ResearchEmail Available
Kenneth HuttnerVice President Clinical Development
Frederic ChereauChief Executive OfficerEmail Available

LogicBio Therapeutics News

12-Sep-19 - LogicBio Therapeutics, Inc. (LOGC) Volume Trending Higher

LogicBio Therapeutics, Inc. (LOGC) has been garnering interest of retail and insitutional invenstors alike as the shares have seen its VMA ...

31-Aug-19 - LogicBio Therapeutics Inc (NASDAQ:LOGC) Given Average Rating of “Buy” by Brokerages

Shares of LogicBio Therapeutics Inc (NASDAQ:LOGC) have been given a consensus recommendation of “Buy” by the six brokerages that are ...

12-Sep-19 - Our Thoughts on LogicBio Therapeutics, Inc. ($LOGC) (2019 ...

On its latest session, LogicBio Therapeutics, Inc. ($LOGC) opened at 12.0, reaching a high of 12.0 and a low of 10.88 before closing at a price ...

LogicBio Therapeutics Funding

DateAmountRoundLead InvestorsReference
2017-06-29$50.0MUndisclosedMultipleArticle

LogicBio Therapeutics Executive Hires

DateNameTitleReference
2018-01-03Matthias JaffeCFOArticle
2018-05-03Sandra PooleCOOArticle
2018-05-24Dean Falbchief scientific officerArticle